Back
Sage Therapeutics Stock Predictions
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
34
SAGE
Sage Therapeutics
Last Price:
$5.49
Seasonality Move:
0.25%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.Sage Therapeutics Stock Forecast
-
Over the next 52 weeks, Sage Therapeutics has on average historically risen by 3.7% based on the past 10 years of stock performance.
-
Sage Therapeutics has risen higher in 3 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
-
Is Sage Therapeutics Stock Undervalued?The current Sage Therapeutics [SAGE] share price is $5.61. The Score for SAGE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
SAGE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Sage Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Sage Therapeutics has on average historically risen by 3.7% based on the past 10 years of stock performance.
Sage Therapeutics Stock Rating
Sell
34
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics overpriced?
-
Sage Therapeutics has risen higher in 3 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
Sage Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com
52-Week Data
52-Week High:
28.26
52-Week Low:
4.62
Prediction Charts
Market Cap:
343.2M
Price in USD:
5.61
Volume:
4.3M
Beta:
1.32
Technical Analysis
SMA50:
6.08
SMA100:
6.97
SMA200:
10.31
52-Wk Change:
-73.13%
Stock Predictions
-
Is Sage Therapeutics stock public?Yes, Sage Therapeutics is a publicly traded company.
-
What is the Sage Therapeutics stock quote today?The Sage Therapeutics stock price is 5.61 USD today.
-
How to buy Sage Therapeutics stock online?You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 5.78 | 5.60 | 5.78 | 5.53 |
| Dec-4 | 5.67 | 5.61 | 5.79 | 5.58 |
| Dec-5 | 5.52 | 5.60 | 5.82 | 5.52 |
| Dec-6 | 5.60 | 5.61 | 5.81 | 5.50 |
| Dec-9 | 5.68 | 5.56 | 5.80 | 5.54 |
| Dec-10 | 5.50 | 5.57 | 5.69 | 5.42 |
| Dec-11 | 5.61 | 5.89 | 5.91 | 5.51 |
| Dec-12 | 5.73 | 5.67 | 5.76 | 5.54 |
| Dec-13 | 5.66 | 5.39 | 5.72 | 5.03 |
| Dec-16 | 5.32 | 5.35 | 5.54 | 5.17 |
| Dec-17 | 5.29 | 5.27 | 5.48 | 5.07 |
| Dec-18 | 5.32 | 5.03 | 5.38 | 4.94 |
| Dec-19 | 5.11 | 5.00 | 5.16 | 4.96 |
| Dec-20 | 5.06 | 5.61 | 5.62 | 4.95 |
Sage Therapeutics Earnings
Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sage Therapeutics Forecast Revenue Growth
Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.10 per share, and an increase next year of $2.77 per share.
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.